Heart health in type 2 diabetes with fatty liver disease
Part of Hormones & metabolism clinical trials.
This study follows people who have both type 2 diabetes and fatty liver disease to see how these conditions affect heart health over time. By participating, you'll help researchers learn more about lowering your risk of heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have been diagnosed with type 2 diabetes for at least 3 months.
- You must have fatty liver disease (a condition where fat builds up in the liver, often related to diabetes or obesity).
- You must be able to attend follow-up visits and live in the study area for a long time.
- You cannot have other types of liver disease, like hepatitis B or C, or drink heavy amounts of alcohol.
- You cannot have severe health issues like advanced cancer, kidney failure, or severe heart disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study looks at people with type 2 diabetes to learn more about fatty liver disease. By joining, you may help doctors better understand how these conditions are linked and improve future care.
This trial tests a specific medical nutrition therapy diet to see if it can reduce liver fat and improve blood sugar control in people with type 2 diabetes and nonalcoholic fatty liver disease. It may help you manage both conditions with a dietary approach.
This study looks at how early biological aging might increase the chance of developing type 2 diabetes in people with a fatty liver (a condition called MASLD). It uses routine health check-up data to understand the link.
This study looks at people with type 2 diabetes who also have fatty liver. The goal is to learn more about this condition in a Saudi group and test approaches that could improve care.
This study is looking for people with type 2 diabetes and fatty liver disease to find better ways to track how the disease progresses. They will use special tests (biomarkers) to see if the liver is getting worse over time.
This study compares new, non-invasive tests to standard liver biopsy for diagnosing fatty liver disease in people with type 2 diabetes or other signs of metabolic syndrome. It aims to see if these simpler tests can replace biopsies.
Hear when a new Type 2 Diabetes (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.